Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

29.20
Delayed Data
As of Apr 29
 -0.57 / -1.91%
Today’s Change
16.75
Today|||52-Week Range
51.89
-11.57%
Year-to-Date
No recent news for Enanta Pharmaceuticals Inc.

Today’s Trading

Previous close29.77
Today’s open29.66
Day’s range28.81 - 29.73
Volume261,584
Average volume (3 months)288,106
Market cap$563.4M
Dividend yield--
Data as of 3:59pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)+127.22%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+236.98%
P/E ratio8.9
Price/Sales4.33
Price/Book2.36

Competitors

 Today’s
change
Today’s
% change
AMPHAmphastar Pharmaceut...-0.26-2.07%
KERXKeryx Biopharmaceuti...+0.18+3.42%
CORTCorcept Therapeutics...-0.30-5.92%
CLVSClovis Oncology Inc-0.57-3.94%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateMay 10, 2016
EPS forecast (this quarter)$0.14
Annual revenue (last year)$160.9M
Annual profit (last year)$79.0M
Net profit margin49.10%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jay R. Luly
Chief Financial Officer &
Senior VP-Administration
Paul J. Mellett
Corporate headquarters
Watertown, Massachusetts

Forecasts

Partner Offers

Search for Jobs